octreotide acetate

The medicine is used to treat acromegaly (excess growth hormone), to relieve symptoms of gastrointestinal tumors, to prevent complications after pancreatic surgery, to inhibit bleeding from gastroesophageal varices, and to treat TSH-secreting pituitary tumors.

Form: solution for injection for infusion

ATC: H01CB02

Manufacturer: Novartis Farma S.p.A. Novartis Farmaceutica S.A. Novartis Farma-Productos Farmaceuticos S.A. Novartis (Hellas) S.A. Novartis Hungary Ltd. Novartis Pharma B.V. Novartis Pharma Ltd. Novartis Pharma Ltd. Novartis Pharma S.A.S. Novartis Sverige Ltd.

The medicine is used to treat acromegaly (excess growth hormone), to relieve symptoms of gastrointestinal tumors, to prevent complications after pancreatic surgery, to inhibit bleeding from gastroesophageal varices in patients with liver cirrhosis, and to treat TSH-secreting pituitary tumors.

Form: solution for injection for infusion

ATC: H01CB02

Manufacturer: Novartis Farma S.p.A. Novartis Farmaceutica S.A. Novartis Farma-Productos Farmaceuticos S.A. Novartis (Hellas) S.A. Novartis Hungaria Kft. Novartis Pharma B.V. Novartis Pharma GmbH Novartis Pharma GmbH Novartis Pharma S.A.S Novartis Sverige AG

The medicine is used to treat acromegaly (a disease related to excess growth hormone), to relieve symptoms caused by excessive hormone secretion by the stomach, intestines, and pancreas, to treat intestinal neuroendocrine tumors, and to treat pituitary tumors that secrete excessive amounts of TSH hormone.

Form: powder and solvent for preparation of suspension for injection

ATC: H01CB02

Manufacturer: Novartis Farma S.p.A., Novartis Farma S.p.A., Novartis Farmaceutica S.A., Novartis Farma-Productos Farmaceuticos S.A., Novartis (Hellas) SA, Novartis Hungary Ltd., Novartis Pharma B.V., Novartis Pharma GmbH, Novartis Pharma GmbH, Novartis Pharma SAS, Novartis Sverige AG

The medicine is used to treat acromegaly (a disease related to excess growth hormone), to relieve symptoms associated with excessive hormone secretion by the stomach, intestines, and pancreas, to treat intestinal neuroendocrine tumors, and to treat pituitary tumors that secrete excessive amounts of TSH hormone.

Form: powder and solvent for preparation of suspension for injection

ATC: H01CB02

Manufacturer: Novartis Farma - Pharmaceutical Products, S.A. Novartis Farma S.p.A. Novartis Pharmaceutical, S.A. Novartis (Hellas) S.A. Novartis Hungary Ltd. Novartis Pharma B.V. Novartis Pharma Ltd. Novartis Pharma Ltd. Novartis Pharma S.A.S. Novartis Sweden Ltd.